Medtronic Plc (MDT) concluded trading on Tuesday at a closing price of $79.88, with 4.8 million shares of worth about $383.7 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.24% during that period and on December 31, 2024 the price saw a gain of about 0.34%. Currently the company’s common shares owned by public are about 1.28B shares, out of which, 1.28B shares are available for trading.
Stock saw a price change of -1.87% in past 5 days and over the past one month there was a price change of -7.70%. Year-to-date (YTD), MDT shares are showing a performance of -3.03% which decreased to -3.03% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $75.96 but also hit the highest price of $92.68 during that period. The average intraday trading volume for Medtronic Plc shares is 5.74 million. The stock is currently trading -2.79% below its 20-day simple moving average (SMA20), while that difference is down -6.93% for SMA50 and it goes to -5.18% lower than SMA200.
Medtronic Plc (NYSE: MDT) currently have 1.28B outstanding shares and institutions hold larger chunk of about 84.67% of that.
The stock has a current market capitalization of $102.78B and its 3Y-monthly beta is at 0.84. PE ratio of stock for trailing 12 months is 24.38, while it has posted earnings per share of $3.28 in the same period. Its PEG reads 4.24 and has Quick Ratio of 1.39 while making debt-to-equity ratio of 0.58. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MDT, volatility over the week remained 0.99% while standing at 1.31% over the month.
Stock’s fiscal year EPS is expected to rise by 4.86% while it is estimated to increase by 7.10% in next year. EPS is likely to grow at an annualized rate of 5.75% for next 5-years, compared to annual growth of -4.12% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by RBC Capital Mkts on October 10, 2024 offering an Outperform rating for the stock and assigned a target price range of between $98 and $105 to it. Coverage by Oppenheimer stated Medtronic Plc (MDT) stock as a Perform in their note to investors on August 21, 2024, suggesting a price target of $94 for the stock. On August 15, 2024, UBS Upgrade their recommendations, while on August 14, 2024, Stifel Downgrade their ratings for the stock with a price target of $85. Stock get a Sell rating from Goldman on May 30, 2024.
